Sarda Proteins share news and announcements
BSE: 519242Agricultural Food & other ProductsSmall Cap
Last close ₹145.05down ₹2.95 (1.99%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹148.00.
52-week range of traded prices to 23 Oct 2026
₹59.95Low, 21 Nov 2025₹174.65High, 25 Sep 2026
- The board meets on 26 Oct 2026 to consider: rights issue of equity shares.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹130 Cr3,764th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 49.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 64
Sarda Proteins board meetings
135 filed, newest first. Page 1 of 3.
Oct 2026
21 Oct · Board meeting
Meeting on 26 Oct 2026: rights issue of equity shares
Sep 2026
7 Sep · Board meeting
Aug 2026
31 Aug · Board meeting
Meeting on 7 Sep 2026: annual general meeting
Jul 2026
31 Jul · Board meeting
Meeting on 5 Aug 202622 Jul · Board meeting
9 Jul · Board meeting
Meeting on 15 Jul 2026: quarterly results1 Jul · Board meeting
Meeting on 4 Jul 2026: increase in authorised capital
Apr 2026
28 Apr · Board meeting
Meeting on 30 Apr 2026: audited results and quarterly results
Mar 2026
18 Mar · Board meeting
Feb 2026
10 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Dec 2025
8 Dec · Board meeting
Meeting on 8 Dec 20258 Dec · Board meeting
Nov 2025
26 Nov · Board meeting
Meeting on 29 Nov 2025: quarterly results6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Sep 2025
8 Sep · Board meeting
2 Sep · Board meeting
Meeting on 8 Sep 2025
Aug 2025
12 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results11 Aug · Board meeting
6 Aug · Board meeting
Meeting on 11 Aug 2025
Jul 2025
22 Jul · Board meeting
Meeting on 26 Jul 2025
May 2025
15 May · Board meeting
12 May · Board meeting
Meeting on 15 May 2025: audited results and quarterly results
Apr 2025
8 Apr · Board meeting
Meeting on 8 Apr 2025: issue of warrants8 Apr · Board meeting
Jan 2025
13 Jan · Board meeting
Meeting on 17 Jan 2025: quarterly results
Dec 2024
24 Dec · Board meeting
18 Dec · Board meeting
Meeting on 24 Dec 2024: issue of warrants and preferential issue of shares
Oct 2024
28 Oct · Board meeting
Meeting on 8 Nov 2024: quarterly results